{ "as_of": "2026-11-06", "cmr": "ca-cm-kg/TSX/CSCI", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# COSCIENS Biopharma Inc. (TSX: CSCI) — research page\n\nAs of 2026-11-06 · ca-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is COSCIENS Biopharma Inc., listed on the TSX under ticker CSCI. Its ISIN is CA22112H1010. The record holds no LEI, as the issuer has no ISIN LEI on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its segment is not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 9 filings in the twelve months to 2026-11-06, across 9 filing days. Of these, 2 are financial statements and 7 are newswire releases. The median gap between filing days is 33.5 days. The latest filing is a newswire release dated 2026-10-19, 18 days before the record date. On the TSX, the median cadence gap is 16 days, the median filings figure is 0.0, and the median latency is 3.0 days across 2270 issuers. In the Life Sciences sector, the median cadence gap is 17.5 days, the median filings figure is 7.0, and the median latency is 14 days across 200 issuers.\n\n## Auditor\n\nThe auditor of record is Deloitte LLP. Its location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting, name change, domicile change or segment move events. The index does not carry a type for these lifecycle lines. The issuer is listed, not halted.\n\n## Orderability\n\nUnder paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read. No research house coverage is recorded.\n\n## Open research\n\nThe field has not been read. No openly published research notes are recorded.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)\n- https://stockanalysis.com/quote/tsx/CSCI/company (identity.isin)\n- https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html (identity.jurisdiction)\n- https://www.tsx.com/en/resource/571 (identity.sector)\n- https://mcp.ca-cm-kg.ai/events/TSX/CSCI (the disclosure lines)\n- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)\n- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.ca-cm-kg.ai/record/TSX/CSCI (the record)\n", "market": "CA", "node": "ca-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-10", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the CA store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "Tavily regex", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html", "state": "sourced", "value": "Deloitte LLP" }, "auditor_firm_id": { "market": "CA", "state": "not_on_record" }, "auditor_location": { "market": "CA", "state": "not_on_record" }, "changes": [] }, "cmr": "ca-cm-kg/TSX/CSCI", "coverage": { "note": "the coverage field has not been read for this issuer", "state": "not_read" }, "disclosure": { "against": { "exchange": { "issuers": 2270, "median_cadence_gap_days": 16, "median_filings": 0, "median_latency_days": 3, "name": "TSX" }, "sector": { "issuers": 200, "median_cadence_gap_days": 17.5, "median_filings": 7, "median_latency_days": 14, "name": "Life Sciences" } }, "by_type": { "financial_statement": 2, "newswire_release": 7 }, "cadence_median_gap_days": 33.5, "filing_days": 9, "filings": 9, "latency_days": 18, "latest": [ { "category": null, "date": "2026-10-19", "source": "https://www.globenewswire.com/news-release/2026/10/19/3383398/0/en/cosciens-announces-new-corporate-presentation-and-provides-update-on-convertible-debenture-offering.html", "title": "COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES", "type": "newswire_release" }, { "category": null, "date": "2026-09-10", "source": "https://www.globenewswire.com/news-release/2026/09/10/3359991/0/en/cosciens-acquires-nualtis-corp.html", "title": "COSCIENS ACQUIRES NUALTIS CORP.", "type": "newswire_release" }, { "category": null, "date": "2026-08-11", "source": "https://www.globenewswire.com/news-release/2026/08/11/3343247/0/en/cosciens-biopharma-inc-reports-q2-2026-results.html", "title": "COSCIENS Biopharma Inc. Reports Q2 2026 Results", "type": "financial_statement" }, { "category": null, "date": "2026-07-03", "source": "https://www.globenewswire.com/news-release/2026/07/03/3321827/0/en/cosciens-biopharma-inc-completes-share-capital-amendment.html", "title": "COSCIENS Biopharma Inc. Completes Share Capital Amendment", "type": "newswire_release" }, { "category": null, "date": "2026-06-23", "source": "https://www.globenewswire.com/news-release/2026/06/23/3315680/0/en/cosciens-biopharma-inc-announces-details-of-share-capital-amendment.html", "title": "COSCIENS Biopharma Inc. Announces Details of Share Capital", "type": "newswire_release" } ], "latest_filing_date": "2026-10-19", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.ca-cm-kg.ai/events/TSX/CSCI", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "TSX" }, "isin": { "read_by": "adjudicated by Claude", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://stockanalysis.com/quote/tsx/CSCI/company", "state": "filled", "value": "CA22112H1010" }, "jurisdiction": { "read_by": "Tavily search + regex extraction from page text", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html", "state": "sourced", "value": "Canada (federal, CBCA)" }, "lei": { "market": "CA", "reason": "no ISIN", "state": "not_on_record" }, "name": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "COSCIENS Biopharma Inc." }, "sector": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Life Sciences" }, "security_type": { "read_by": "TMX listed-companies workbook (exchange list, monthly; data month named in the source column)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/en/resource/571 (tsx-and-amp-tsxv-listed-companies-2026-08-14-en.xlsx, data as of 31-Jul-2026)", "state": "sourced", "value": "Corporate" }, "segment": { "market": "CA", "state": "not_on_record" }, "ticker": { "read_by": "tsx.com company directory (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*", "state": "sourced", "value": "CSCI" }, "website": { "market": "CA", "state": "not_on_record" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": [], "domicile_change": [], "listing": [], "name_change": [], "segment_move": [] }, "market": "CA", "node": "ca-cm-kg", "numbers_hash": "sha256:f8e6ab6d05fda95ab80fb3f42dd5c16eb1e32369d4195e8cdb2d1c20532937cf", "open_research": { "rows": [], "state": "not_read" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "Paragraph (o) of the definition", "Paragraph (q) of the definition" ], "outcomes": { "Paragraph (o) of the definition": { "determinable": true, "signal": "ACM-200" }, "Paragraph (q) of the definition": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.ca-cm-kg.ai/book/aio.json", "door": "https://mcp.ca-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/ca/kyp-know-your-product-ni-31-103/r1", "section": "ca.aio.v11" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.ca-cm-kg.ai/record/TSX/CSCI", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-08", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100", "value": "listed, not halted" } }, "numbers_hash": "sha256:f8e6ab6d05fda95ab80fb3f42dd5c16eb1e32369d4195e8cdb2d1c20532937cf", "path": "/ca/TSX/CSCI", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is COSCIENS Biopharma Inc., listed on the TSX under ticker CSCI. Its ISIN is CA22112H1010. The record holds no LEI, as the issuer has no ISIN LEI on the record. Its security type is Corporate, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). Its segment is not on the record. Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 9 filings in the twelve months to 2026-11-06, across 9 filing days. Of these, 2 are financial statements and 7 are newswire releases. The median gap between filing days is 33.5 days. The latest filing is a newswire release dated 2026-10-19, 18 days before the record date. On the TSX, the median cadence gap is 16 days, the median filings figure is 0.0, and the median latency is 3.0 days across 2270 issuers. In the Life Sciences sector, the median cadence gap is 17.5 days, the median filings figure is 7.0, and the median latency is 14 days across 200 issuers.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Deloitte LLP. Its location is not on the record. The record holds no auditor changes.", "title": "Auditor" }, { "id": "events", "text": "The record holds no listing, delisting, name change, domicile change or segment move events. The index does not carry a type for these lifecycle lines. The issuer is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "The field has not been read. No research house coverage is recorded.", "title": "Coverage" }, { "id": "open_research", "text": "The field has not been read. No openly published research notes are recorded.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. The live record began on 2026-09-10. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.tsx.com/json/company-directory/search/tsx/^*" }, { "for": "identity.isin", "source": "https://stockanalysis.com/quote/tsx/CSCI/company" }, { "for": "identity.jurisdiction", "source": "https://www.stocktitan.net/sec-filings/CSCI/20-f-cosciens-biopharma-inc-files-annual-report-foreign-issuer-d894827f0f8f.html" }, { "for": "identity.sector", "source": "https://www.tsx.com/en/resource/571" }, { "for": "the disclosure lines", "source": "https://mcp.ca-cm-kg.ai/events/TSX/CSCI" }, { "for": "the halt flag", "source": "https://iiroc.mediaroom.com/index.php?s=2429&l=100" }, { "for": "the orderability chapter", "source": "https://mcp.ca-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.ca-cm-kg.ai/record/TSX/CSCI" } ], "title": "COSCIENS Biopharma Inc. (CSCI) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }